Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05309551 · ClinicalTrials.gov registry record · NA
Inspiratory Muscle Training Immediately After Lung Transplantation
A NA study of Muscle Weakness and Rehabilitation, sponsored by Ohio State University.
- Active
- Registry status
- NA
- Development phase
- 90
- Enrollment target
- 1
- Study location
NCT05309551 is a NA study of Muscle Weakness and Rehabilitation that is active but no longer recruiting, run by Ohio State University. The registered enrollment target is 90 participants, above the 71-participant average among 25 other Muscle Weakness trials with a reported enrollment target (27% higher). The trial reports 1 study location across 1 state.
The verdict
NCT05309551, a NA study of Muscle Weakness and Rehabilitation, is active but no longer recruiting, sponsored by Ohio State University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
- 1
- Study location
Study Summary
Following lung transplantation (LTX), patients may exhibit respiratory and skeletal muscle weakness that will affect exercise capacity, increase dyspnea and fatigue, limit activities of daily living (ADL) and decrease quality of life. Inspiratory muscle training (IMT) has been extensively studied in a variety of non-LTX populations and research has shown that IMT improves exercise capacity, diaphragmatic thickness, and reduced dyspnea during activities of daily living and improved quality of life in patients with advanced lung disease. The aim of this randomized controlled study is to investigate the benefits of providing inspiratory muscle training via use of an inspiratory muscle trainer device in addition to standard physical therapy in the acute phase of rehabilitation following LTX. Patients targeted for enrollment will be those with any type of advanced lung disease requiring LTX with the objective of demonstrating improvements in respiratory muscle recovery, perceived dyspnea, severity of fatigue, and overall functional status following the transplant procedure.
Conditions Studied
Interventions
- DEVICE IMT- Intervention group
- DEVICE IMT- Placebo group
Study Locations (1)
Ohio
- The Ohio State University Wexner Medical Center - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2022-04-20 |
| Est. Completion | 2026-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05309551
The ClinicalTrials.gov registry entry for NCT05309551 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 71-participant average among 25 other Muscle Weakness trials with a reported enrollment target (27% higher). The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Muscle Weakness appearing as the primary indexed condition, and to 2 interventions - of which IMT- Intervention group is the first listed.
NCT05309551 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT05309551 about?
NCT05309551 is a clinical study titled "Inspiratory Muscle Training Immediately After Lung Transplantation". Following lung transplantation (LTX), patients may exhibit respiratory and skeletal muscle weakness that will affect exercise capacity, increase dyspnea and fatigue, limit activities of daily living (ADL) and decrease quality of life. Inspiratory muscle training (IMT) has been extensively studied i...
What is the current status of trial NCT05309551?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 90 participants. The study started on 2022-04-20. Estimated completion is 2026-05.
What conditions does trial NCT05309551 study?
This clinical trial studies the following conditions: Muscle Weakness, Rehabilitation, Lung Transplantation, Chronic Lung Disease.
What interventions are being tested in trial NCT05309551?
The interventions under investigation include: IMT- Intervention group (DEVICE), IMT- Placebo group (DEVICE).
Who is sponsoring clinical trial NCT05309551?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05309551 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Muscle Weakness
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effect of Weight Loss on Intermuscular Adipose Tissue (IMAT) Signaling
RECRUITING · NA
-
FIT Exercise in 30d of ULLS-induced Muscle Disuse
RECRUITING · NA
-
THRIVE Well Cancer FDTN/Exercise_Creatine Supplementation
RECRUITING · NA
-
Imaging Skeletal Muscle Mitochondrial OXPHOS Activity In Acute Lymphoblastic Leukemia Survivors
RECRUITING · NA
-
Assessing The Effects of Exercise, Protein, and Electric Stimulation On Intensive Care Unit Patients Outcomes
ACTIVE NOT RECRUITING · NA
-
Neuromodulation for Prevention of Intensive Care Unit Acquired Weakness and Post Intensive Care Syndrome
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.